Forget About Little Blue Pills: Research on Shockwave Therapy Shows Drug-Free Results

Forget About Little Blue Pills: Research on Shockwave Therapy Shows Drug-Free ResultsIt’s been used to treat conditions ranging from cancer to kidney stones, and research shows amazing results for erectile dysfunction.

Not everybody wants to mar the magic of the moment by stopping to swallow a pill. And then there’s the factor of waiting for the results. Erectile Dysfunction (ED) medications may be widely prescribed, but they do have their downsides.

Impracticality for spur-of-the-moment usage is one of the reasons why there’s been an upsurge in interest in the results from a European study that used low-intensity extracorporeal shockwave therapy (LI-ESWT) as a highly successful treatment for men with ED.

A history of therapeutic applications

Low-Intensity Extracorporeal Shockwave Therapy (LI-ESWT) has been used to treat conditions ranging from cancer to kidney stones. It’s interesting to medical professionals and patients alike because the procedure is both non-invasive and it’s not a drug.

LI-ESWT works by increasing the blood flow to targeted areas of the body. It results in the formation of new blood vessels in this tissue. The process is known as neovascularization, and scientific studies have shown it’s highly effective in creating significant improvement for men who are experiencing ED.

In one example, nearly 60% of participants in a 2015 study published in the Scandinavian Journal of Urology benefitted from the therapy, showing a marked improvement in erectile dysfunction. What’s more, almost 20% of these men were still experiencing positive results 24 weeks after only five LI-ESWT treatments. This led the researchers to conclude that in some cases, LI-ESWT therapy is a possible cure for some men who now have to resort to ED medications.

Results in the United States

Shockwave Therapy Results in the United StatesYou don’t have to travel to Scandinavia—the site of the study—to experience the results of LI-ESWT. Here in the US, the GAINSWave Medical Advisory Board has developed the GAINSWave™ Therapy protocol for ED patients.

It’s a simple in-office procedure that takes 6 to 12 treatments of about 20 minutes apiece. Since its inception, physicians applying the protocol report that there are no major side effects, and the procedure has promoted the same long-term results as the European study.

Shockwaves

In non-medical terms, the therapy applies pulsating shockwaves that stimulate the release of growth factors and result in the generation of new blood vessels. LI-ESWT also breaks up plaque formations that can cause blockage in existing blood vessels and activates dormant stem cells, which leads to cell growth.

GAINSWave Therapy addresses the degenerative process men experience as they age. Tissue is regenerated, which means that it targets the source of the problem, rather than simply treating the symptoms with injections or pills.

No need to wait

This therapy—which now has more than 40 clinical studies proving its effectiveness—is also beneficial for men who aren’t experiencing significant ED. GAINSWave has been shown to spur enhancement for patients of many ages and at different levels of performance. The therapy is ideal for any man who wants to proactively address the decline in their sexual performance that will come with age.

Timing in life is everything, as the saying goes. If you’re tired of trying to sync a pill to a moment of intimacy, it’s time to explore what might be a more lasting solution.

GAINSWave Therapy is an elective procedure, so it’s not covered by insurance. You just might discover, however, that it’s a better investment. The therapy involves no drugs, and the results have been shown to last much longer than popping that pill.

For more information on GAINSWave, or to find a qualified provider near you, connect with us online today.

Alvaro Ocampo M.D.

Dr. Ocampo is an expert physician specializing in anti-aging, hormone therapy, pathology and environmental medicine. He received his medical degree from Columbia State Medical School in Montreal, Canada. Dr. Ocampo’s comprehensive medical experience includes working as medical officer for the U.S. Public Health Service and C.D.C, National Institute for Occupational Health, medical director for the U.S. Public Health Service, and as a Principal Investigator for American Pharmaceutical Companies.